Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient

Robert M. Esterl; Navyash Gupta; Paul J. Garvin

doi:10.1097/00002826-199619030-00008

Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient

Robert M. Esterl, Navyash Gupta, Paul J. Garvin

Department of Surgery

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Abstract

Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.

Original language	English (US)
Pages (from-to)	259-266
Number of pages	8
Journal	Clinical neuropharmacology
Volume	19
Issue number	3
DOIs	https://doi.org/10.1097/00002826-199619030-00008
State	Published - 1996

Keywords

Blindness
Cyclosporine
Kidney-pancreas transplant
Neurotoxicity

ASJC Scopus subject areas

Clinical Neurology
Pharmacology (medical)
Pharmacology

Access to Document

10.1097/00002826-199619030-00008

Cite this

@article{cc3aa15770c549288c2020a4efea6c7c,

title = "Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient",

abstract = "Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.",

keywords = "Blindness, Cyclosporine, Kidney-pancreas transplant, Neurotoxicity",

author = "Esterl, {Robert M.} and Navyash Gupta and Garvin, {Paul J.}",

year = "1996",

doi = "10.1097/00002826-199619030-00008",

language = "English (US)",

volume = "19",

pages = "259--266",

journal = "Clinical neuropharmacology",

issn = "0362-5664",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient

AU - Esterl, Robert M.

AU - Gupta, Navyash

AU - Garvin, Paul J.

PY - 1996

Y1 - 1996

N2 - Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.

AB - Blindness is an extremely rare complication of cyclosporine neurotoxicity. In all 10 cases in the literature, this form of blindness is completely reversible with the reduction or withdrawal of cyclosporine. We describe the first case of sudden, complete, and permanent blindness within 36 h after administration of intravenous cyclosporine in a kidney-pancreas transplant recipient.

KW - Blindness

KW - Cyclosporine

KW - Kidney-pancreas transplant

KW - Neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=0029880893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029880893&partnerID=8YFLogxK

U2 - 10.1097/00002826-199619030-00008

DO - 10.1097/00002826-199619030-00008

M3 - Article

C2 - 8726545

AN - SCOPUS:0029880893

SN - 0362-5664

VL - 19

SP - 259

EP - 266

JO - Clinical neuropharmacology

JF - Clinical neuropharmacology

IS - 3

ER -

Permanent blindness after cyclosporine neurotoxicity in a kidney-pancreas transplant recipient

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this